CFO4Life Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,957
Closed -$279K 224
2024
Q2
$279K Sell
1,957
-739
-27% -$105K 0.05% 154
2024
Q1
$346K Buy
2,696
+425
+19% +$54.6K 0.06% 139
2023
Q4
$235K Sell
2,271
-86
-4% -$8.9K 0.04% 155
2023
Q3
$214K Buy
+2,357
New +$214K 0.05% 143